{"id":"https://openalex.org/W4302773352","doi":"https://doi.org/10.1016/j.clinthera.2022.09.008","title":"Assessing the Cost-effectiveness of a Hypothetical Disease-modifying Therapy With Limited Duration for the Treatment of Early Symptomatic Alzheimer Disease","display_name":"Assessing the Cost-effectiveness of a Hypothetical Disease-modifying Therapy With Limited Duration for the Treatment of Early Symptomatic Alzheimer Disease","publication_year":2022,"publication_date":"2022-10-06","ids":{"openalex":"https://openalex.org/W4302773352","doi":"https://doi.org/10.1016/j.clinthera.2022.09.008","pmid":"https://pubmed.ncbi.nlm.nih.gov/36210219"},"language":"en","primary_location":{"id":"doi:10.1016/j.clinthera.2022.09.008","doi":"https://doi.org/10.1016/j.clinthera.2022.09.008","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.clinthera.2022.09.008","pdf_url":"https://www.clinicaltherapeutics.com/article/S0149-2918(22)00322-8/pdf","source":{"id":"https://openalex.org/S185879095","display_name":"Clinical Therapeutics","issn_l":"0149-2918","issn":["0149-2918","1879-114X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.clinicaltherapeutics.com/article/S0149-2918(22)00322-8/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019055956","display_name":"Malaz A. Boustani","orcid":"https://orcid.org/0000-0003-0330-677X","observed_orcids":["https://orcid.org/0000-0003-0330-677X"]},"institutions":[{"id":"https://openalex.org/I4388446366","display_name":"Indiana University Indianapolis","ror":"https://ror.org/03eftgw80","country_code":"US","type":"education","lineage":["https://openalex.org/I4388446366","https://openalex.org/I592451"]},{"id":"https://openalex.org/I4394709130","display_name":"Indiana University School of Medicine","ror":"https://ror.org/02ets8c94","country_code":"US","type":"education","lineage":["https://openalex.org/I4394709130","https://openalex.org/I592451"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Malaz Boustani","raw_affiliation_strings":["Division of Internal Medicine and Geriatrics, Indiana University School of Medicine, Indianapolis, Indiana"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Internal Medicine and Geriatrics, Indiana University School of Medicine, Indianapolis, Indiana","institution_ids":["https://openalex.org/I4388446366","https://openalex.org/I4394709130"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013337549","display_name":"Erin Gautier Doty","orcid":"https://orcid.org/0000-0003-1400-4427","observed_orcids":["https://orcid.org/0000-0003-1400-4427"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Erin G. Doty","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, Indiana"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, Indiana","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060938706","display_name":"Louis P. Garrison","orcid":"https://orcid.org/0000-0002-9468-4989","observed_orcids":["https://orcid.org/0000-0002-9468-4989"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Louis P. Garrison","raw_affiliation_strings":["The CHOICE Institute, Department of Pharmacy, University of Washington, Seattle, Washington"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The CHOICE Institute, Department of Pharmacy, University of Washington, Seattle, Washington","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027402674","display_name":"Lee J. Smolen","orcid":"https://orcid.org/0000-0002-9931-8945","observed_orcids":["https://orcid.org/0000-0002-9931-8945"]},"institutions":[{"id":"https://openalex.org/I4210105725","display_name":"Medical Decision Modeling (United States)","ror":"https://ror.org/01h42mb65","country_code":"US","type":"company","lineage":["https://openalex.org/I4210105725"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lee J. Smolen","raw_affiliation_strings":["Medical Decision Modeling Inc, Indianapolis, Indiana"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Decision Modeling Inc, Indianapolis, Indiana","institution_ids":["https://openalex.org/I4210105725"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007379923","display_name":"Mark A. Belger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095227","display_name":"Eli Lilly (United Kingdom)","ror":"https://ror.org/00psab413","country_code":"GB","type":"company","lineage":["https://openalex.org/I168537998","https://openalex.org/I4210095227"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Mark Belger","raw_affiliation_strings":["Eli Lilly and Company, Windlesham, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Windlesham, United Kingdom","institution_ids":["https://openalex.org/I4210095227"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058526962","display_name":"Timothy M. Klein","orcid":"https://orcid.org/0000-0002-4428-6181","observed_orcids":["https://orcid.org/0000-0002-4428-6181"]},"institutions":[{"id":"https://openalex.org/I4210105725","display_name":"Medical Decision Modeling (United States)","ror":"https://ror.org/01h42mb65","country_code":"US","type":"company","lineage":["https://openalex.org/I4210105725"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Timothy M. Klein","raw_affiliation_strings":["Medical Decision Modeling Inc, Indianapolis, Indiana"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Decision Modeling Inc, Indianapolis, Indiana","institution_ids":["https://openalex.org/I4210105725"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039849825","display_name":"Daniel R. Murphy","orcid":"https://orcid.org/0000-0002-2329-668X","observed_orcids":["https://orcid.org/0000-0002-2329-668X"]},"institutions":[{"id":"https://openalex.org/I4210105725","display_name":"Medical Decision Modeling (United States)","ror":"https://ror.org/01h42mb65","country_code":"US","type":"company","lineage":["https://openalex.org/I4210105725"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel R. Murphy","raw_affiliation_strings":["Medical Decision Modeling Inc, Indianapolis, Indiana"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Decision Modeling Inc, Indianapolis, Indiana","institution_ids":["https://openalex.org/I4210105725"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001431413","display_name":"Russel Thomas Burge","orcid":"https://orcid.org/0000-0001-7907-6400","observed_orcids":["https://orcid.org/0000-0001-7907-6400"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Russel Burge","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, Indiana"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, Indiana","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":null,"display_name":"J.K. Wall","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J.K. Wall","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, Indiana"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, Indiana","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5015927873","display_name":"Joseph A. Johnston","orcid":"https://orcid.org/0000-0003-3913-9256","observed_orcids":["https://orcid.org/0000-0003-3913-9256"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Joseph A. Johnston","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, Indiana. Electronic address: johnston_joseph_a@lilly.com"],"raw_orcid":"https://orcid.org/0000-0003-3913-9256","affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, Indiana. Electronic address: johnston_joseph_a@lilly.com","institution_ids":["https://openalex.org/I168537998"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5015927873"],"corresponding_institution_ids":["https://openalex.org/I168537998"],"apc_list":{"value":4090,"currency":"USD","value_usd":4090},"apc_paid":{"value":4090,"currency":"USD","value_usd":4090},"fwci":2.8127,"has_fulltext":true,"cited_by_count":17,"citation_normalized_percentile":{"value":0.91725239,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":99},"biblio":{"volume":"44","issue":"11","first_page":"1449","last_page":"1462"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.7567999958992004,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.7567999958992004,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.16269999742507935,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.07400000095367432,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9679999947547913},{"id":"https://openalex.org/keywords/disease-modifying-therapy","display_name":"disease-modifying therapy","score":0.9700000286102295},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.9829999804496765},{"id":"https://openalex.org/keywords/mild-cognitive-impairment","display_name":"mild cognitive impairment","score":0.6819999814033508},{"id":"https://openalex.org/keywords/fixed-duration-treatment","display_name":"fixed-duration treatment","score":0.6949999928474426},{"id":"https://openalex.org/keywords/amyloid-plaque-clearance","display_name":"amyloid plaque clearance","score":0.7379999756813049},{"id":"https://openalex.org/keywords/quality-adjusted-life-years","display_name":"quality-adjusted life years","score":0.8180000185966492},{"id":"https://openalex.org/keywords/markov-state-transition-model","display_name":"Markov state-transition model","score":0.8169999718666077},{"id":"https://openalex.org/keywords/long-term-care","display_name":"long-term care","score":0.6539999842643738},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.5929999947547913},{"id":"https://openalex.org/keywords/incremental-cost-effectiveness-ratio","display_name":"incremental cost-effectiveness ratio","score":0.7559999823570251},{"id":"https://openalex.org/keywords/societal-perspective","display_name":"societal perspective","score":0.9710000157356262},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.6439999938011169},{"id":"https://openalex.org/keywords/indirect-costs","display_name":"indirect costs","score":0.515999972820282}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9107576608657837},{"id":"https://openalex.org/C3019080777","wikidata":"https://www.wikidata.org/wiki/Q1754768","display_name":"Cost effectiveness","level":2,"score":0.5883593559265137},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5623830556869507},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.48777133226394653},{"id":"https://openalex.org/C64332521","wikidata":"https://www.wikidata.org/wiki/Q614165","display_name":"Quality-adjusted life year","level":3,"score":0.4808957576751709},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.41520771384239197},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.347353994846344},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.26353830099105835},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.0},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019057","descriptor_name":"Quality-Adjusted Life Years","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1016/j.clinthera.2022.09.008","doi":"https://doi.org/10.1016/j.clinthera.2022.09.008","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.clinthera.2022.09.008","pdf_url":"https://www.clinicaltherapeutics.com/article/S0149-2918(22)00322-8/pdf","source":{"id":"https://openalex.org/S185879095","display_name":"Clinical Therapeutics","issn_l":"0149-2918","issn":["0149-2918","1879-114X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Therapeutics","raw_type":"journal-article"},{"id":"pmid:36210219","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/36210219","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical therapeutics","raw_type":"Journal Article"},{"id":"pmh:oai:scholarworks.indianapolis.iu.edu:1805/41020","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/1805/41020","pdf_url":null,"source":{"id":"https://openalex.org/S4306400987","display_name":"IUScholarWorks (Indiana University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I592451","host_organization_name":"Indiana University","host_organization_lineage":["https://openalex.org/I592451"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Publisher","raw_type":"Article"}],"best_oa_location":{"id":"doi:10.1016/j.clinthera.2022.09.008","doi":"https://doi.org/10.1016/j.clinthera.2022.09.008","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.clinthera.2022.09.008","pdf_url":"https://www.clinicaltherapeutics.com/article/S0149-2918(22)00322-8/pdf","source":{"id":"https://openalex.org/S185879095","display_name":"Clinical Therapeutics","issn_l":"0149-2918","issn":["0149-2918","1879-114X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Therapeutics","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4302773352.pdf","grobid_xml":"https://content.openalex.org/works/W4302773352.grobid-xml"},"referenced_works_count":37,"referenced_works":["https://openalex.org/W2031772714","https://openalex.org/W2038593189","https://openalex.org/W2039585634","https://openalex.org/W2049570029","https://openalex.org/W2058056848","https://openalex.org/W2060252294","https://openalex.org/W2111769573","https://openalex.org/W2114983566","https://openalex.org/W2119084244","https://openalex.org/W2122843800","https://openalex.org/W2138904731","https://openalex.org/W2318933458","https://openalex.org/W2518059812","https://openalex.org/W2519603001","https://openalex.org/W2788249140","https://openalex.org/W2803651213","https://openalex.org/W2906765081","https://openalex.org/W2923168235","https://openalex.org/W2930696305","https://openalex.org/W3014253589","https://openalex.org/W3112231948","https://openalex.org/W3118389339","https://openalex.org/W3137826907","https://openalex.org/W3152692563","https://openalex.org/W3163695789","https://openalex.org/W3195630219","https://openalex.org/W3205834137","https://openalex.org/W3210814279","https://openalex.org/W3210916380","https://openalex.org/W4205869346","https://openalex.org/W4206817121","https://openalex.org/W4211104519","https://openalex.org/W4211238543","https://openalex.org/W4221124351","https://openalex.org/W4225741213","https://openalex.org/W6751506411","https://openalex.org/W6810228092"],"related_works":["https://openalex.org/W4283523433","https://openalex.org/W2170317538","https://openalex.org/W2967771094","https://openalex.org/W3108815706","https://openalex.org/W2981037569","https://openalex.org/W3028235623","https://openalex.org/W3021784507","https://openalex.org/W2545602259","https://openalex.org/W3205834137","https://openalex.org/W2980600196"],"abstract_inverted_index":{"PURPOSE:":[0],"Clinical":[1],"trials":[2],"have":[3],"produced":[4],"promising":[5],"results":[6],"for":[7,11,135,177,345,359,373],"disease-modifying":[8],"therapies":[9],"(DMTs)":[10],"Alzheimer's":[12],"disease":[13],"(AD);":[14],"however,":[15],"the":[16,27,49,142,208,231,241,272,293,305,308,319,326,340,346,364],"evidence":[17],"on":[18],"their":[19],"potential":[20],"cost-effectiveness":[21,28,50,225,384],"is":[22],"limited.":[23],"This":[24],"study":[25],"assesses":[26],"of":[29,51,181,195,203,258,284,357,368],"a":[30,34,43,52,99,178,249,355,374],"hypothetical":[31,53,93,250],"DMT":[32,54,94,161,251],"with":[33,66,248,381],"limited":[35,375],"treatment":[36,162,165,175,198,212,247,280,287,314,316,361,369],"duration":[37,180,367,376],"in":[38,102,255,271,279,313],"AD.":[39,76,108],"METHODS:":[40],"We":[41,158],"developed":[42],"Markov":[44],"state-transition":[45],"model":[46],"to":[47,72,82,97,118,266,311],"estimate":[48],"plus":[55],"best":[56],"supportive":[57],"care":[58,151,154,243,342],"(BSC)":[59],"versus":[60,252],"BSC":[61,253],"alone":[62],"among":[63],"Americans":[64],"living":[65],"mild":[67,75,84,107],"cognitive":[68],"impairment":[69],"(MCI)":[70],"due":[71,81],"AD":[73,77,148,171,189,221,322],"or":[74,131,155,184,216],"states":[78],"included":[79],"MCI":[80,105],"AD,":[83,85,87,89],"moderate":[86],"severe":[88,170,188,220],"and":[90,106,123,137,145,150,192,207,302,318,334,349,363,366],"death.":[91],"A":[92],"was":[95,116,295,307],"assumed":[96,117],"confer":[98],"30%":[100],"reduction":[101],"progression":[103],"from":[104,128,141,339],"The":[109,263],"base":[110],"case":[111],"annual":[112,360],"drug":[113],"acquisition":[114],"cost":[115,233],"be":[119],"$56,000.":[120],"Other":[121],"medical":[122],"indirect":[124],"costs":[125,362],"were":[126,139,228,331],"obtained":[127,140],"published":[129,143],"literature":[130,144],"list":[132],"prices.":[133],"Utilities":[134],"patients":[136,168,186,196,210,285],"caregivers":[138],"varied":[146],"by":[147,276],"state":[149,323],"setting":[152],"(community":[153],"long-term":[156],"care).":[157],"considered":[159],"3":[160],"strategies:":[163],"(1)":[164],"administered":[166,176],"until":[167,213,217],"reached":[169,187,219],"(continuous":[172],"strategy),":[173,191,292],"(2)":[174],"maximum":[179],"18":[182,214],"months":[183,201,215,290],"when":[185],"(fixed-duration":[190],"(3)":[193],"40%":[194,283],"discontinuing":[197,286],"at":[199,288],"6":[200,289],"because":[202],"amyloid":[204],"plaque":[205],"clearance":[206],"remaining":[209],"continuing":[211],"they":[218],"(test-and-discontinue":[222,291],"strategy).":[223],"Incremental":[224],"ratios":[226],"(ICERs)":[227],"calculated":[229],"as":[230],"incremental":[232],"per":[234,260,268,297],"quality-adjusted":[235],"life-year":[236],"(QALY)":[237],"gained.":[238,262,299],"FINDINGS:":[239],"From":[240,325],"health":[242,341],"sector":[244,343],"perspective,":[245,329],"continuous":[246],"resulted":[254],"an":[256],"ICER":[257,264,294,306],"$612,354":[259],"QALY":[261,269,298],"decreased":[265],"$157,288":[267],"gained":[270],"fixed-duration":[273],"strategy,":[274],"driven":[275],"large":[277],"reductions":[278],"costs.":[281],"With":[282],"$125,631":[296],"In":[300],"sensitivity":[301],"scenario":[303],"analyses,":[304],"most":[309],"sensitive":[310],"changes":[312],"efficacy,":[315,370],"cost,":[317],"initial":[320],"population":[321],"distribution.":[324],"modified":[327],"societal":[328],"ICERs":[330],"6.3%,":[332],"20.4%,":[333],"25.1%":[335],"lower":[336],"than":[337],"those":[338],"perspective":[344],"continuous,":[347],"fixed-duration,":[348],"test-and-discontinue":[350],"strategies,":[351],"respectively.":[352],"IMPLICATIONS:":[353],"Under":[354],"set":[356],"assumptions":[358],"magnitude":[365],"DMTs":[371],"used":[372],"may":[377],"deliver":[378],"value":[379],"consistent":[380],"accepted":[382],"US":[383],"thresholds.":[385]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":4}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2022-10-07T00:00:00"}